To Avoid Exposure to Toxoplasmosis, Kaye Should Ask Other Family Members to

Saudi Pharm J. 2021 Apr; 29(iv): 343–350.

A pilot written report on screening for gestational/built toxoplasmosis of pregnant women at delivery in the Eastern Province of Saudi Arabia

Fatimah Salim Al-Yami

^aSection of Medical Laboratory, King Fahad Military Medical Complex-Dhahran, Saudi arabia

Fazal Karim Dar

^bCollege of Medicine and Medical Sciences, Arabian Gulf University, Manama, Bahrain

Abdulrahman Ismaeel Yousef

^cCollege of Medicine and Medical Sciences, Arabian Gulf Academy, Manama, Bahrain

Bader Hamad Al-Qurouni

^dDepartment of Medical Laboratory, Male monarch Fahad Military Medical Complex-Dhahran, Kingdom of saudi arabia

Lamiaa Hamad Al-Jamea

^eDepartment of Clinical Laboratory Sciences, Prince Sultan Armed services College of Health Sciences, Dhahran, Saudi Arabia

Ali A. Rabaan

^fMolecular Diagnostic Laboratory, Johns Hopkins Aramco Healthcare, Dhahran, Kingdom of saudi arabia

Jenifer Vecina Quiambao

^gVice Deanship of Postgraduate Studies and Research, Prince Sultan Military Higher of Wellness Sciences, Dhahran, Saudi Arabia

Zechariah Jebakumar Arulanantham

^gVice Deanship of Postgraduate Studies and Research, Prince Sultan Military Higher of Health Sciences, Dhahran, Saudi Arabia

Alexander Woodman

^{one thousand}Vice Deanship of Postgraduate Studies and Enquiry, Prince Sultan War machine Higher of Wellness Sciences, Dhahran, Kingdom of saudi arabia

Received 2020 December 16; Accustomed 2021 Mar half-dozen.

Abstruse

Groundwork

Globally, built toxoplasmosis remains a significant cause of morbidity and bloodshed, and outbreaks of T. gondii infection stand for a major public health threat, especially in developing countries. Prove in the literature indicates that only a few studies have been conducted on the incidence of maternal and built toxoplasmosis in Kingdom of saudi arabia. This prospective study aims to measure the overall incidence of congenital toxoplasmosis, both patent and 'silent' infection, amidst significant women in the Eastern Province of Saudi Arabia. The report would endeavour to relate the string blood results with the time of seroconversion in the mother, underlining the importance of early intervention in such cases.

Methods

Five hundred paired maternal/string blood samples were tested for anti-Toxoplasma IgG or IgM antibodies. Samples were collected during delivery from mother and newborn (cord blood) from November 2011 to May 2012. But positive for anti-Toxoplasma IgG or/and IgM cord blood was processed for existent-fourth dimension PCR for confirmation. The age of mothers ranged from 16 to 45 years.

Results

The sample subjects were tested during child delivery for specific IgG and IgM antibodies confronting Toxoplasmosis, of which 21.0% (n = 105) mother/baby pairs were institute serologically positive for anti-Toxoplasma IgG antibodies. The rate of maternal seropositivity for anti-Toxoplasma IgM antibodies was found among 4 participants (0.8%), who were also seropositive for anti-Toxoplasma IgG antibodies. None of the children tested positive for anti-Toxoplasma IgM antibodies, even those born to mothers with IgM positive. All 105 string blood tests in the written report sample were confirmed negative past real-time PCR. The seroprevalence of Toxoplasma IgG antibodies increased with maternal age, parity, and was significantly higher in women who gave nativity to children with congenital anomalies (p = 0.008).

Determination

The findings of the current study signal a dire need to develop and implement preventive programs against Toxoplasma gondii infection, as well as a health didactics programme on how to avert toxoplasmosis for all seronegative women during pregnancy.

Keywords: Congenital toxoplasmosis, IgG antibody, IgM antibody, Newborn, Pregnancy, Toxoplasma gondii

1. Background

Toxoplasmosis is an endemic zoonotic disease caused by the protozoan parasite Toxoplasma gondii (T. gondii), infecting all warm-blooded animals (e.g., members of the true cat family Felidae), and humans who serve as intermediate hosts (Centers for Affliction Control and Prevention Us, 2020, The National Wellness Service UK, 2020). T. gondii is an intracellular protozoan parasite, a member of the phylum Apicomplexa, class Coccidia. Information technology is ubiquitous and characterized by its power to infect a broad range of hosts and many unlike hosts cell types. T. gondii parasite can persist in humans (and other animals) for long periods, perhaps even throughout life (Centers for Illness Command and Prevention USA, 2020, Singh, 2013, McAuley, 2013).

Globally, congenital toxoplasmosis remains a significant cause of morbidity and mortality, and outbreaks of T. gondii infection correspond a major public wellness threat, especially in developing countries (Centers for Disease Control and Prevention U.s.a., 2020, Torgerson and Mastroiacovo, 2013, El Bissati et al., 2018). The most important estimate of the global incidence of congenital toxoplasmosis was a meta-analysis published in 2013 in the Message of the World Health Organization. According to this report, the global annual incidence of built toxoplasmosis of 190,100 cases, equivalent to a inability burden of 1.20 million disability-adjusted life years (DALY) (95% CI: 0.76–i.90). Approximately i-3rd of the world's population is infected with this pathogenic parasite, including populations in Europe, Southward America, Africa and parts of Asia (Torgerson and Mastroiacovo, 2013, El Bissati et al., 2018).

There are iv principal ways of human toxoplasmosis transmission: (1) eating undercooked, contaminated meat or shellfish; (2) unintentional ingestion of undercooked, contaminated meat or shellfish after handling them and not washing easily thoroughly; (three) eating food that was contaminated by knives, utensils, cutting boards, and other foods that have had contact with raw, contaminated meat or shellfish; (4) drinking h2o contaminated with T. gondii; (v) accidentally swallowing the parasite through contact with true cat feces with Toxoplasma; (5) receiving an infected organ transplant or infected blood by transfusion, although this is rare; (5) Mother-to-child (congenital) transmission. Infected women can transmit the infection transplacentally to their unborn fetus (Centers for Disease Control and Prevention U.s., 2020, Singh, 2013, McAuley, 2013).

Toxoplasma can exist transmitted from mother to fetus in approximately 40% case, when pregnant women are infected with T. gondii during pregnancy, resulting in abortion or fetal abnormalities (Kaye, 2011). The parasite can cross the intestinal epithelial barrier, disseminate throughout the body and localize in the placenta, producing progressively larger focal lesions (Centers for Disease Control and Prevention Usa, 2020, Montoya and Liesenfeld, 2004, Munoz et al., 2011). Those infected, have very few symptoms because the allowed system of a healthy person commonly prevents the parasite from causing illness. However, pregnant women and those with weakened immune systems should be conscientious; for them, Toxoplasma infection tin can cause serious health problems (Singh, 2013, McAuley, 2013).

The prevalence of positive serological tests for T. gondii varies in different regions and cultures. As such, in Saudi Arabia, prevalence studies accept shown that 29.5–35.6% of pregnant women were infected with T. gondii during pregnancy (Al-Harthi et al., 2006). Data testify that the seroprevalence (i.e., serological prevalence) among meaning Saudi women varies regionally. The results of the study among significant women and newborn infants at the King Fahd Hospital in Al-Khobar (Eastern Province), showed that a very small number (1/175, 0.57%) of meaning women were seroconverted during pregnancy. At the aforementioned fourth dimension, the specific IgG positivity was significantly high (69/175, 39.4) (Al-Qurashi et al., 2001). While a study in the Al-Ahsa region found that of the 554 significant women, 51.4% were seropositive for IgG antibiotic, and viii.8% were IgM antibiotic (Al-Mohammad et al., 2010). According to the most recent report conducted among Saudi pregnant women from Riyadh (due north = 250), T. gondii was prevalent with 32.5% for IgG and 6.four% for IgM antibodies (Alghamdi et al., 2016).

Studies investigating possible chance factors for T. gondii infection in pregnant Saudi women have shown that serological prevalence is highest among those with low educational levels in the Western Province (Al-Harthi et al., 2006). While the highest serological prevalence rates were among people living in rural areas in the Eastern Province (Al-Harthi et al., 2006). However, these data are outdated, and new research is needed to study and report on the current burden of T. gondii infection in pregnant Saudi women.

Until recently, only a few studies have been conducted on the incidence of maternal and congenital toxoplasmosis in Kingdom of saudi arabia. This prospective written report aims to measure out the overall incidence of built toxoplasmosis, both patent and 'silent' infection, among pregnant women in the Eastern Province of Saudi arabia. Furthermore, the report would attempt to relate the string claret results with the time of seroconversion in the mother, underlining the importance of early intervention in such cases. Since the detection of parasites in string blood past PCR is a applied and cost-effective approach to the early neonatal diagnosis of congenital toxoplasmosis. In the Kingdom of saudi arabia, as in the United States, antenatal screening relies on a single serum sample taken during the antenatal period to detect antibodies to toxoplasma. A sample, which is often obtained either at the terminate of the get-go trimester or in the second or third trimester, is the only source of information about whether a fetus is at run a risk. Based on the results and findings, this report will serve as a basis for the evolution of neonatal screening policies in the Eastern Province of Saudi Arabia.

2. Materials & methods

Study Surface area and Participants: This written report was conducted in King Fahad Military Medical City (KFMMC) in the Eastern Province.

Report Design and Samples choice: Prospective study of prenatal and postpartum diagnosis of gestational and congenital toxoplasmosis. A sample of n = 500 pregnant women at delivery, enrolled in this study from November 2011 to May 2012. The age of the participants ranged from 16 to 45 years old, with the mean age 29.2 ± 5.ix (median historic period 28 years). Paired claret samples were collected from both mother and newborn (string blood) at birth. Samples were randomly selected from all pregnant women at delivery and without exclusion criteria.

Ethical consideration: All participant-mothers signed a written informed consent form after the purpose of the written report was explained to them. The Research and Ethics committee approved the written report of the College of Medicine and Medical Sciences, Arabian Gulf University, Kingdom of Bahrain, and the Enquiry and Ethics Committee of KFMMC.

Data Collection. The questionnaire was administered among all selected mothers on their age, history of spontaneous abortion, stillbirth, congenital anomalies. The birth and clinical condition of the newborn including gender, weight, gestational age, and head circumference at nativity was obtained from the infirmary's antenatal carte du jour.

Sample Drove and Laboratory Processing. Claret samples were nerveless in vacuum serum separation tubes to measure specific anti-Toxoplasma antibodies. Five milliliters of peripheral blood were taken from delivering mothers by venipuncture. 5 milliliters of string claret were similarly collected at the time of delivery under sterile conditions, accessing either an umbilical string vessel or one of the fetal surfaces of the placenta. Blood was immune to clot, centrifuged to sediment the clot, and serum aseptically transferred to a sterile 10 ml capped tube. Sera were then stored at − threescore° C until assayed. Five milliliters of each infant'southward string blood were too nerveless in Potassium EDTA for the real-time PCR detection of Toxoplasma DNA and refrigerated at 2–8 °C until assayed. Just cord claret found positive for anti-Toxoplasma IgG or/and IgM were processed for existent-time PCR for confirmation.

ii.1. Serological assays

Serum from the umbilical string blood and maternal blood was analyzed in batches of 50 – 100 paired specimens for both anti-Toxoplasma IgM and IgG by chemiluminescent microparticle immunoassay (CMIA) technology in Architect i 2000 System using commercial kits (Abbott Diagnostics) with appropriate positive and negative controls provided by the manufacturer.

2.2. Detection of T. gondii B1 gene by existent-time PCR

PCR has been performed post-obit the manufacturer's instructions (QuantiTect SYBR® Green, Qiagen, Frg) on Applied Biosystems 7500 Real-Fourth dimension PCR System with a 96-well plate with SYBR Green I dye, a double-stranded DNA bounden dye, to detect PCR products as they accumulate during PCR cycles. Qualitative analysis of the PCR product was achieved by cook bend analysis that occurs mail-PCR. T. gondii tachyzoites RH strain were provided past BRC Toxoplasma-lab parasitology-French republic and were used as a positive command. Detailed protocols sequences are available upon request. The target DNA for real-fourth dimension PCR amplification is the published sequence of the 35-fold repetitive B1 factor of the T. gondii RH strain. B1 gene is highly conserved and one of the near sensitive and specific genes of T. gondii. The primer sequences received from Thermo Fisher Scientific were as follows:

Forward primer	TOXO-F: 5′-TCCCCTCTGCTGGCGAAAAGT-three′
Reverse primer	TOXO-R: 5′-AGCGTTCGTGGTCAACTATCGATTG-3′

• • The total volume in the reaction tube was twenty µL, the primer concentrations used for SYBR Green I dye was 50 nM of forrard and reverse primer.
• • The reaction mixture was incubated for 10 min at 95 °C for initial denaturation followed by 40 cycles of fifteen s at 95 °C, i min at 60 °C.
• • The products were loaded to 1.v% agarose gel with an 0.1 µg/ml ethidium bromide stain and electrophoresed at eighty Five for 45 min, and the bands were visualized nether UV light (Fig. one).
  

  Visualized bands under UV light. Analysis of PCR product by 1.five% agarose gel electrophoresis. PCR was based on the amplification of a 100 bp fragment of the B1 factor. Lane 1: molecular weight markers, lane ii: negative control, and lanes three–vii: positive results for the B1 gene.

2.iii. Data analysis

Data compilation, tabulation, and statistical analysis were performed using Windows Excel and the Statistical Data for Social Sciences (SPSS) 20 packages. Statistical significance of the relationship between any possible variables used with appropriate p values and comparing of groups was carried out past Chi-foursquare. All statistical tests were interpreted at the 5% level of significance (p > 0.05), non statistically pregnant.

3. Results

The average number of deliveries was 2.i ± i.94, with a median of 2 deliveries. The almost frequent parity history was 2–iv deliveries (229; 45.eight%). Equally summarized in Table 1, the prevailing number of mothers (n = 345, 69.0%) recruited in this study had no history of abortions. While most of the studied women had no history of abnormal pregnancy outcomes, intrauterine fetal death was recorded in due north = 7 cases (one.4%), and neonatal bloodshed in north = 14 (2.viii%), while congenital anomalies were seen in due north = 4 (0.8%) of cases. Of n = 500 women, north = 478 (95.v%) had been tested for both specific anti-Toxoplasma IgG and IgM antibodies at diverse times during the pregnancy; n = 22 (four.4%) had remained untested during this antenatal period.

Tabular array 1

General and obstetric characteristics of n = 500 pregnant women.

Obstetric Characteristic	No	%
Age grouping (year)
16–20	30	six.0
21–thirty	284	56.8
≥31	186	37.ii
Tested in trimester
First	241	48.ii
Second	108	21.vi
3rd	129	25.8
Not tested	22	4.4
Previous abortion
None	345	69.0
One abortion	105	21.0
More than 1 abortion	50	10.0
Parity
None	117	23.4
1	101	20.two
2–four	229	45.8
≥five	53	ten.6
Previous intra-uterine fetal decease (IUFD)
None	493	98.six
Yep	seven	one.4
	Previous Neonatal Death (NND)
None	486	97.2
Yeah	14	2.8
Previous congenital anomalies (CA)
None	496	99.2
Yes	4	0.8

Of n = 500 women tested during delivery of specific IgG and IgM antibodies against toxoplasmosis, north = 105 (21.0%) were constitute to be serologically positive for anti-Toxoplasma IgG antibodies. The seropositivity rate for anti-Toxoplasma IgM antibodies was 0.viii% (n = four mothers), who were as well seropositive for anti-Toxoplasma IgG antibodies. Consequently, n = 395 (79.0%) of these Saudi women remained susceptible to acute Toxoplasma infection in childbearing age. Co-ordinate to existent-fourth dimension PCR, due north = 105 cord blood in the studied samples were confirmed negative. Subsequently six months, follow-upwards showed that all those children whose mothers were positive for anti-Toxoplasma IgM became negative for Toxoplasma IgG antibodies. This report plant no evidence for congenital toxoplasmosis in children at birth when screened by serology or existent-time PCR. Although the PCR results were negative and the serology results also turned negative, ascertainment at half-dozen months of historic period may exist helpful. The main advantage of PCR is its sensitivity in detecting very low levels of T. gondii.

It was observed that seropositivity for IgG antibodies increased with historic period, with the lowest charge per unit of 10% amid the youngest age group of 16–20 years old; information technology increased to 16.four% at the age of 21–30 years, and a maximum prevalence rate of 29.half dozen% was seen in the historic period group of 31–45 years of pregnant women. These IgG seroprevalence rate differences between different age-groups were statistically meaning (p = 0.001). The increment observed in the electric current report may be associated with a more considerable time run a risk of exposure with age. IgM seropositivity also increased with age, although the numbers were too small-scale, no differences were statistically pregnant (Table 2). There is a probability that we would get statistical significance when we increase the sample size. However, the IgM positive cases are few in number though we have a sufficient sample size. Therefore, we cannot exist sure that when we increase the sample size, there volition be a significant difference since there may or may not be IgM positive cases to prove meaning results.

Table 2

Distribution of IgG and IgM seroprevalence of toxoplasmosis amongst different historic period groups of Saudi women at delivery in the Eastern Province of Saudi arabia.

Age group (year)	N tested	IgG Negative		IgG Positive		P	IgM negative		IgM positive		P
		No	%	No	%		No	%	No	%
xvi–20	thirty	27	xc.0	3	x	10two = xiii.81 P = 0.001 Significant	30	100.0	0	0.0	Xtwo = two.51 P = 0.29
21–xxx	284	237	83.five	47	16.5		283	99.half dozen	i	0.4
31–45	186	131	70.iv	55	29.6		183	98.iv	3	1.half-dozen
Total	500	395	79.0	105	21.0		496	99.two	4	0.8

All samples were taken during delivery, thus there were no abortions during the study. The written report cites the entire history of abortion. Every bit shown in Table 3, women who had a history of abortion were more than predisposed to seropositive for anti-T. gondii IgG. The level of seropositivity in women who had i abortion was 21.0%, and the highest rate of 32.0% was observed in women who had more i ballgame. There was no statistically significant association between prior abortion and the seropositivity of T. gondii IgG.

Tabular array 3

Association of Toxoplasma seropositivity with obstetric history of women at commitment.

Obstetric History	No. tested	IgG positive			IgM positive
Abortion		No	%		No	%
0	345	67	nineteen.4	10two = 4.166 P = 0.125	four	1.2	X2 = 1.812 P = 0.404
1	105	22	21.0		0	0.0
≥ ii	l	16	32.0		0	0.0
Total	500	105	21.0		iv	0.8
Parity		No	%	102 = 7.979 P = 0.046	No	%	Ten2 = 1.997 P = 0.573
0	117	eighteen	15.4		1	0.ix
1	101	19	xviii.8		0	0.0
2–four	229	50	21.8		iii	1.iii
≥5	53	eighteen	34.0		0	0.0
Total	500	105	21.0		four	0.8
NND*		No	%	X2 = 0.002 p = 0.968	No	%	X2 = 0.116 p = 0.733
None	486	102	21.0		4	0.8
Yeah	xiv	3	21.4		0	0.0
Total	500	105	21.0		4	0.eight
IUFD*		No	%	X2 = 0.245 p = 0.620	No	%	Ten2 = 0.057 p = 0.811
None	493	103	twenty.9		iv	0.8
Aye	7	ii	28.six		0	0.0
	500	105	21.0		four	0.8
CA*		No	%	Ten2 = 7.087 p = 0.008	No	%	X2 = 0.033 p = 0.857
None	496	102	20.half-dozen		4	0.8
Yes	iv	3	75.0		0	0.0
Total	500	105	21.0		4	0.8

The lowest level of seropositivity − 19.4% was observed in women without a history of abortion. In women with a history of abortion, IgM seropositivity was not observed. IgG seropositivity increased again with parity with the everyman seropositivity rate − xv.4% among unborn babies and the highest − 34.0% amid women with ≥ 5 previous births, and this trend was observed with increasing maternal age. The deviation was statistically significant (X2 = 7.97, P = 0.046). The IgM seropositivity charge per unit differences were non significant due to small numbers in different categories.

The IgG seropositivity rates showed no differences between women who had experienced neonatal decease (21.iv%) and those who had not (21.0%). Seropositivity rate was higher (28.6%) in women with a history of intrauterine fetal death compared with those (20.9%) with no such history. At that place was a significantly higher seroprevalence rate (75.0%) amongst women with a history of congenital anomalies compared with those (20.six%) with no such history. This showed a meaning clan (X2 = 7.87, P = 0.008) with maternal seropositivity for anti-Toxoplasma IgG antibodies. In women with such a previous adverse obstetric outcome, IgM seropositivity was non observed.

The distribution of seroprevalence levels of anti-Toxoplasma IgG and IgM antibodies amidst mothers with different birth characteristics of their children is presented in Tabular array 4. The seropositivity rates of anti-Toxoplasma IgG were similar among mothers who gave birth to boys (21.1%) or girls (21.viii%). Similarly, the level of seropositivity for anti-Toxoplasma IgM was 0.viii%, no matter whether mothers gave nascency to boys or girls. The seropositivity for anti-T. gondii IgG in mothers classified according to their children's gestational age showed a 25.0% charge per unit for gestation age ≥ 41 weeks; 20.0% for gestation age ≤ 34 weeks; and 21.0% for gestation historic period between 35 and 40 weeks. These differences were not statistically meaning.

Table iv

Relationship of Maternal Seroprevalence of Toxoplasma gondii IgG and IgM antibodies with birth characteristics of their babies at delivery.

Characteristics	No tested	IgG positive		P value	IgM positive		P value
Gender		No	%		No	%
Male child	239	48	20.1	X2 = 0.232 P = 0.630	2	0.8	102 = 0.008 P = 0.930
Girl	261	57	21.8		2	0.8
Full	500	105	21.0		4	0.8
Maturity		No	%		No	%	X2 = 0.074 P = 0.964
≤34	5	1	20.0	Ten2 = 0.042 P = 0.979	0	0.0
35-40	491	103	21.0		4	0.viii
≥41	4	1	25.0		0	0.0
Total	500	105	21.0		four	0.8
Nativity weight (g)1		No	%		No	%	X2 = 5.78 P = 0.123
≤1899	iv	0	0.0	X2 = 4.52 P = 0.211	0	0.0
1900–2499	37	5	xiii.5		i	2.vii
2500–3999	435	92	21.1		two	0.five
≥4000	24	8	33.3		1	4.2
Total	500	105	21.0		4	0.viii
Caput circumference (cm)1		No	%		No	%	X2 = 0.024 P = 0.988
≤29	1	0	0.0	Ten2 = vii.812 P = 0.020	0	0.0
30-40	497	103	xx.seven		4	0.eight
≥41	two	2	100.0		0	0.0
Total	500	105	21.0		4	0.8
Baby condition		No	%		No	%	X2 = 0.049 P = 0.997
Normal	494	102	20.6	Xii = 8.1 P = 0.044	4	0.eight
Congenital Anomalies	i	0	0.0		0	0.0
preterm	3	one	33.3		0	0.0
Babe dice due multiples CA	2	2	100.0		0	0.0
Total	500	105	21.0		four	0.viii

Four mothers who gave birth to babies with nascence weight of ≤ 1899 one thousand were all seronegative for toxoplasmosis. The seemingly higher rate of seropositivity (33.3%) was among mothers giving nascency to babies with weight of ≥ 4000 k, which was not statistically significant.

Statistically significant association (X2 = 7.812, P = 0.020) was found between maternal seropositivity for Toxoplasmosidue south and large head circumference in newborns, as well as with other adverse outcomes include preterm and baby dice due to multiple congenital anomalies (X2 = viii.one, P = 0.044), fifty-fifty though the number of babies born with such issues was small-scale. As shown in Fig. two, a statistical assay of the results for gamble factors revealed a significant relationship between the seropositivity of maternal anti-Toxoplasma IgG and life in rural or urban areas (P = 0,000), as well as women who were enlightened of the manner of disease transmission (p = 0.023). No significant association was plant between seroprevalence of anti-Toxoplasma IgG antibodies and such hazard factors as eating raw or undercooked meat or sheltering cats.

Human relationship between seroprevalence of T. gondii IgG antibodies and exposure to risk cistron.

4. Give-and-take

Bear witness in the literature indicates that only a few studies have been conducted on the incidence of maternal and congenital toxoplasmosis in Saudi Arabia. Furthermore, currently, at that place is no newborn screening strategy for the early diagnosis and treatment of infected children in the Kingdom. This prospective study is designed to airplane pilot a neonatal screening programme and apply more than sensitive serological and PCR techniques to notice Toxoplasma infection in both female parent and child in a sample population in the Eastern Province of Saudi Arabia. The findings and results of the current report tin can serve equally a footing for developing neonatal screening policies in the Eastern Province of Saudi Arabia, taking into account the health program and the Kingdom's health system outlook.

The present study was undertaken to determine the Toxoplasma infection rates in a sample population of 500 Saudi national women who delivered at KFMMC between November 2011 and May 2012. The age of the participants ranged from 16 to 45 years old, with the hateful age 29.two ± 5.9 (median age 28 years). Paired claret samples were collected from both mother and newborn (string claret) at nativity. Samples were randomly selected from all pregnant women at commitment and without exclusion criteria. In the present report, a seroprevalence of 21.0% is reported in women which is lower than the rates previously reported from other parts of KSA. The 0.eight% of women tested at commitment had both positive IgG and IgM antibodies. Findings have shown that like to previous findings not all women with positive IgG and IgM examination results may be said to have a recently acquired infection, as anti-Toxoplasma IgM antibodies may persist for several months, making it hard to calculate the time of exposure (Pelloux et al., 1997).

We institute a relatively low risk of female parent-to-child manual in women with untreated Toxoplasma infection during pregnancy. All mothers who may have get infected during pregnancy gave nativity to babies with no evidence of a built toxoplasmosis infection. Thus, the incidence of congenital toxoplasmosis in our study population was in the range from 0% to 40% as in the UK and from 0 to 100/10,000 live births elsewhere (Joynson, 1992, Mozzatto and Procianoy, 2003).

The results of our study confirm previous studies, i.due east., the relationship of parity with seropositivity. Studies in Al-Ahsa and the southwestern region of Saudi Arabia have shown that IgG seroprevalence confronting T. gondii significantly correlates with increased parity. This may be due to an increase in exposure (Al-Mohammad et al., 2010, Almushait et al., 2014). Prove shows that women, infected before pregnancy, become immune to reinfection, which does not pose a threat to any subsequent fetal development. Nonetheless, gestational age during seroconversion is an essential factor in both the incidence of congenital infections and its severity. The likelihood of developing a placental infection increases with gestational historic period, while the severity of fetal damage is highest if transmission occurred in early pregnancy (Remington and Desmonts, 1990).

In our examination of previous obstetric outcomes and occurrence of built anomalies, nosotros found a significant association of such outcomes with T. gondii infection. This is in understanding with the results of a recent Saudi report reported from Al-Ahsa, which showed adverse obstetric outcomes significantly associated with T. gondii infection (Al-Mohammad et al., 2010). Previous investigations on the association between obstetric outcomes and T. gondii infection were reported but not found to exist of statistical significance (Almushait et al., 2014).

Further findings of current analysis showed that built toxoplasmosis was associated with an increased hazard of premature nascency and a shorter gestational period in women who seroconverted to 20 weeks, while we institute no show of a significant association betwixt congenital toxoplasmosis and low birth weight upon commitment. These observations are consistent with studies among members of the European Multicenter Written report of congenital toxoplasmosis (Freeman et al., 2005), likewise as written report by Fochi et al. (2015), where comparing of birth weight with dissimilar serological profiles did not reveal statistically pregnant differences. There has been a relationship between the seroprevalence of Toxoplasma IgG and the head circumference of newborns. Yet, no show of a link between the seroprevalence of Toxoplasma infection and other growth characteristics of born children was plant. Two out of 500 born children died during the first month of life due to multiple congenital anomalies, and both were built-in to mothers with a history of toxoplasmosis. Several run a risk factors influence prevalence, including age, cultural practices regarding hygienic eating habits, pets, and the environment (Tenter et al., 2001, Pappas et al., 2009). The known adventure factors most probable account for the observed seroprevalence levels of differences within Saudi Arabia. In the current report, a statistically significant association was establish between maternal seropositivity for toxoplasmosis and big caput circumference in newborns, as well as with other adverse outcomes, including the premature expiry of the child and death from multiple congenital anomalies. Concerning the cause of death in infants from ether due to confirmed toxoplasmosis, the number was not statistically significant, therefore we cannot confirm this. In addition, it was difficult to conduct whatsoever analysis of the deceased infants.

Based on the results, we tin can suggest the frequent consumption of undercooked meat was not associated with an increased risk of chronic T. gondii infection. This is consistent with findings from the southwestern region of Saudi Arabia (Almushait et al., 2014). While studies in Al-Ahsa and Makkah (Al-Harthi et al., 2006, Al-Mohammad et al., 2010) prove an association of often undercooked consumption meat with an increased risk of T. gondii infection during pregnancy. Nevertheless, it is hard to explain this regional disparity in Saudi arabia. Considering these discrepancies in findings, we can confirm previous hypothesis that increased consumption of meat from animals raised indoors, and large-calibration imports of frozen meat may explain the differences in accessibility, hence the discrepancies between the prevalence of the parasite in animals and humans in the region. The right temperature for cooking meat is critical to reducing the infection of T. gondii.

Several studies have shown that the prevalence and manual of T. gondii are higher in rural than in urban (Ades and Nokes, 1993). Since the Eastern Province of Saudi Arabia, namely the city of Dhahran, is surrounded by villages and where the study infirmary is allocated, many women from these rural areas came for commitment. In the nowadays study, it was noted that women from rural or Bedouin communities were significantly more seropositive of anti-T. gondii IgG than from urban areas. Although, information technology is possible that these women once lived in rural areas and so moved to urban areas of the Eastern Province. These findings are consistent with the report by Al-Qurashi et al. (2001) who reported that the highest seroprevalences of anti-T. gondii IgG were institute amid people who lived in rural areas, and Al-Mohammad et al. (2010) suggested that rural living may correlate with increased exposure to soil potentially contaminated with oocysts (Al-Qurashi et al., 2001, Al-Mohammad et al., 2010). Moreover, recent information by Rivera et al. (2019) confirmed that significant differences were found in serological prevalence analyzes betwixt urban and peri-urban areas in Chascomus, Argentina. The authors, suggested that higher seroprevalence in peri-urban areas may be associated with poor socioeconomic conditions and/or poor peri-urban environments, which is a take a chance factor to be considered when planning health care for pregnant women (Rivera et al., 2019).

There was no significant difference in the level of seropositivity between illiterate and literate report participants regarding the relationship of Toxoplasma seroprevalence with education. This finding is supported by a similar written report reported in Turkey (Ertug et al., 2005). Notwithstanding, Al-Harthi et al. (2006) indicated that the western region reported the highest seroprevalences of anti-T. gondii IgG among people with a low level of teaching (Al-Harthi et al., 2006). This may be since women in rural Saudi arabia have fewer opportunities for formal education. Our report showed that there is a meaning deviation between the prevalence of toxoplasmosis infection in women who had knowledge and awareness of the manual methods of T. gondii and those who did not. This is consistent with data from Hashemite kingdom of jordan (Jumaian, 2005). In Saudi arabia, antenatal screening depends on a single serum sample obtained during the antenatal period to detect Toxoplasma-antibodies. Thus, wellness education programs on how to avoid toxoplasmosis, such as eating habits and hygienic practices that are identified as risk factors during pregnancy, maybe a more toll-constructive approach to preventing built toxoplasmosis and reducing the burden of infection than implementing a national program screening.

Nevertheless, the development of more sensitive and discriminatory methods is required to confirm the immunological status of people infected with T. gondii. The nigh toll-constructive methods are those with the best combination of sensitivity and specificity and fewer equivocal results. Nosotros used a polymerase chain reaction to discover T. gondii Deoxyribonucleic acid in the umbilical cord blood of mothers suspected of having an infection. Using this procedure, nosotros were able to amplify and directly find an individual organism's DNA from cord blood samples. This sensitivity level also allowed us to identify the BI factor from purified Deoxyribonucleic acid samples containing one copy of Deoxyribonucleic acid in string claret. According to Burg et al., 1989, James et al., 1996, PCR had the highest level of sensitivity and specificity in the diagnosis of (prenatal and postnatal) toxoplasmosis compared with serological tests (Burg et al., 1989, James et al., 1996). A single PCR-positive sample nerveless in the first one-half of pregnancy, combined with an IgG-positive examination outcome might confirm a chief infection, even in the presence of serologic results that are difficult to interpret due to the lack of subsequent follow-up during pregnancy (Nimri et al., 2004). The sensitivity of PCR from amniotic fluid has been too shown to exist affected by the phase of pregnancy in which maternal infection occurs. It is notable that testing amniotic fluid for T. gondii was establish to be effective nearly iv weeks following infection, which is the usual period for the parasitemic stage in the infected mother (Rorman et al., 2006). Conversely, a negative result by PCR testing amniotic fluid on prenatal diagnosis cannot rule out built infection (Abdul-Ghani, 2011). Amniotic fluid puncture for prenatal diagnosis should non be used as a routine procedure because of its associated chance of fetal loss. Observational studies reported that spontaneous abortion rate was one.7% afterwards amniocentesis and 0.7% in the control group (Tabor et al., 1986, Alfirevic et al., 2003).

Our report suggests that the detection of parasite Dna in cord blood using PCR is an important, cost-effective tool for the diagnosis of newborns probably infected with T. gondii. As there is no official notification of congenital toxoplasmosis infections within KSA, the true number of cases is not known. If a national prenatal antibiotic screening programs were introduced in KSA, 79% of not-immune meaning women would have to be followed serologically until commitment; we ended that repeated screening during pregnancy would exist expensive. This test with a better sensitivity is relatively low cost compared to serological tests currently used in our diagnostic laboratories. However, the benefits of early treatment with the regimens currently available have non been evaluated in a randomized controlled trial, and the optimum elapsing of treatment is not known.

Based on this written report'south findings, we propose the need to establish preventive programs against T. gondii infection, a wellness education plan regarding how to avoid toxoplasmosis for all seronegative women during pregnancy together with the National Board of Health screening for congenital toxoplasmosis of all neonates in Saudi Arabia, could, in theory, be a price-constructive approach to preventing and managing built toxoplasmosis. The potential benefit refers not but to the initiation of specific anti-toxoplasmosis treatment, simply importantly identifies this susceptible group of infants who require total clinical evaluation and facilitates their enrollment in early on intervention services as appropriate. Futurity studies tin be developed regarding ToRCH (i.e., (toxoplasmosis, rubella, cytomegalovirus and Canker simplex virus) co-infections and maternal/neonatal sequels.

five. Limitations

In improver to the study's main findings, several limitations were identified, that should be addressed in the future to confirm these findings and add together boosted information. As the part of the current research molecular and serology was performed. The current study did not include the avidity. However, Ig ELISA test can be developed in our future work. Although the PCR results were negative and the serology results too turned negative, observation at six months of age may be helpful. The master advantage of PCR is its sensitivity in detecting very depression levels of T. gondii. Future research can be developed for bioassay. For the purposes of this study, we wanted to empathise how important the history of the parameters with seropositivity was. In future enquiry, we tin can categorize seropositive cases according to antibody titers, and appraise their correlation with sequelae (east.one thousand., history of abortions, etc.).

Announcement of Competing Interest

The authors declare that they accept no known competing financial interests or personal relationships that could take appeared to influence the work reported in this paper.

Acknowledgments

The authors of electric current inquiry would like to thank the staff of Department of Laboratory Medicine in King Fahd Military Medical Complex for their support, cooperation and extra endeavour they did during the practical part of this study. The authors highly capeesh the aid of the staff at Princess Al-Jawhara Center and Department of Microbiology in Arabian Gulf University.

The authors are especially grateful to all the individuals who participated in this airplane pilot study. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Footnotes

Peer review under responsibility of King Saud University.

References

• Abdul-Ghani R. Polymerase concatenation reaction in the diagnosis of congenital toxoplasmosis: more two decades of evolution and evaluation. Parasitol. Res. 2011;108(three):505–512. [PubMed] [Google Scholar]
• Ades A.E., Nokes D.J. Modeling age-and fourth dimension-specific incidence from seroprevalence: toxoplasmosis. Am. J. Epidemiol. 1993;137(9):1022–1034. doi: ten.1093/oxfordjournals.aje.a116758. [PubMed] [CrossRef] [Google Scholar]
• Alfirevic Z., Sundberg M., Brigham S. Amniocentesis and chorionic villus sampling for prenatal diagnosis. The Cochrane database. Syst. Rev. 2003;3:CD003252. doi: 10.1002/14651858.CD003252. [PMC complimentary article] [PubMed] [CrossRef] [Google Scholar]
• Alghamdi J., Elamin M.H., Alhabib S. Prevalence and genotyping of Toxoplasma gondii among Saudi pregnant women in Saudi Arabia. Saudi. Pharm. J. 2016;24(six):645–651. doi: 10.1016/j.jsps.2015.05.001. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Al-Harthi S.A., Jamjoom One thousand.B., Ghazi H.O. Seroprevalence of Toxoplasma gondii among significant women in Makkah, Saudi Arabia. Umm Al-Qura Univ. J. Sci. Med. Eng. 2006;18(ii):217–227. [Google Scholar]
• Al-Mohammad H.I., Amin T.T., Balaha Thousand.H., Al-Moghannum M.S. Toxoplasmosis among the pregnant women attending a Saudi maternity hospital: seroprevalence and possible risk factors. Ann. Trop. Med. Parasitol. 2010;104(half dozen):493–504. doi: 10.1179/136485910X12786389891443. [PubMed] [CrossRef] [Google Scholar]
• Almushait M.A., Dajem S.Thousand., Elsherbiny N.M., Eskandar M.A., Al Azraqi T.A., Makhlouf L.M. Seroprevalence and risk factors of Toxoplasma gondii infection among meaning women in s western Kingdom of saudi arabia. J. Parasit. Dis. 2014;38(i):4–10. doi: 10.1007/s12639-012-0195-z. [PMC free commodity] [PubMed] [CrossRef] [Google Scholar]
• Al-Qurashi A.R., Ghandour A.M., Obeid O.Due east., Al-Mulhim A., Makki S.K. Seroepidemiological written report of Toxoplasma gondii infection in the human population in the Eastern Region. Saudi Med. J. 2001;22(1):xiii–18. https://europepmc.org/commodity/med/11255603 [PubMed] [Google Scholar]
• Burg J.L., Grover C.M., Pouletty P., Boothroyd J.C. Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J. Clin. Microbiol. 1989;27(8):1787–1792. https://jcm.asm.org/content/27/8/1787.short [PMC costless article] [PubMed] [Google Scholar]
• Centers for Disease Control and Prevention Us, 2020. Parasites – Toxoplasmosis Toxoplasma infection. https://www.cdc.gov/parasites/toxoplasmosis/alphabetize.html (accessed 12 September 2020).
• El Bissati K., Levigne P., Lykins J., Adlaoui Due east.B., Barkat A., Berraho A. Global initiative for built toxoplasmosis: an observational and international comparative clinical analysis. Emerg. Microbes. Infect. 2018;7(1):1–14. doi: 10.1038/s41426-018-0164-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Ertug S., Okyay P., Turkmen Thousand., Yuksel H. Seroprevalence and take a chance factors for toxoplasma infection among significant women in Aydin province. Turkey. BMC Public Health. 2005;5:66. doi: 10.1186/1471-2458-v-66. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Freeman K., Oakley L., Pollak A., Buffolano West., Petersen East., Semprini A.East. Clan between congenital toxoplasmosis and preterm nascence, depression birthweight and minor for gestational age birth. BJOG: Int. J. Obstet. Gynecol. 2005;112(i):31–37. doi: 10.1111/j.1471-0528.2004.00299.ten. [PubMed] [CrossRef] [Google Scholar]
• Fochi G.One thousand., Baring S., Spegiorin L.C., Vaz-Oliani D.C., Galão East.A., Oliani A.H. Prematurity and depression birth weight did not correlate with anti-toxoplasma gondii maternal serum profiles-a Brazilian report. PLoS ONE. 2015;10(vii):e0132719. doi: 10.1371/journal.pone.0132719. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• James G.S., Sintchenko Five.Thousand., Dickeson D.J., Gilbert G.L. Comparison of cell culture, mouse inoculation, and PCR for detection of Toxoplasma gondii: effects of storage weather on sensitivity. J. Clin. Microbiol. 1996;34(6):1572–1575. doi: x.1128/JCM.34.6.1572-1575.1996. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Joynson D.H. Epidemiology of toxoplasmosis in the U.K. Scand. J. Infect. Dis. Suppl. 1992;84:65–69. PMID: 1290077. [PubMed] [Google Scholar]
• Jumaian Due north.F. Seroprevalence and hazard factors for Toxoplasma infection in significant women in Jordan. E. Mediterr. Health. J. 2005;11(ane–ii):45–51. PMID: 16532670. [PubMed] [Google Scholar]
• Kaye A. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. J. Pediatr. Health. Care. 2011;25(half dozen):355–364. doi: 10.1016/j.pedhc.2010.04.008. [PubMed] [CrossRef] [Google Scholar]
• McAuley J.B. Toxoplasmosis in children. Pediatr. Infect. Dis. J. 2013;27(two):161–162. doi: x.1097/INF.0b013e3181658abb. [PubMed] [CrossRef] [Google Scholar]
• Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet. 2004;363(9425):1965–1976. doi: 10.1016/S0140-6736(04)16412-X. [PubMed] [CrossRef] [Google Scholar]
• Mozzatto L., Procianoy R.S. Incidence of congenital toxoplasmosis in southern Brazil: a prospective study. Rev. Inst. Med. Trop. Sao Paulo. 2003;45(3):147–151. doi: x.1590/s0036-46652003000300006. [PubMed] [CrossRef] [Google Scholar]
• Munoz Thousand., Liesenfeld O., Heimesaat M.1000. Immunology of Toxoplasma gondii. Immunol. Rev. 2011;240(1):269–285. doi: 10.1111/j.1600-065X.2010.00992.x. [PubMed] [CrossRef] [Google Scholar]
• Nimri L., Pelloux H., Elkhatib 50. Detection of Toxoplasma gondii DNA and specific antibodies in high-risk pregnant women. Am. J. Trop. Med. Hyg. 2004;71(6):831–835. PMID: 15642979. [PubMed] [Google Scholar]
• Pappas G., Roussos N., Falagas M.E. Toxoplasmosis snapshots: global condition of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int. J. Parasitol. 2009;39(12):1385–1394. doi: ten.1016/j.ijpara.2009.04.003. [PubMed] [CrossRef] [Google Scholar]
• Pelloux H., Fricker-Hidalgo H., Goullier-Fleuret A., Ambroise-Thomas P. Detection of anti-Toxoplasma immunoglobulin M in pregnant women. J. Clin. Microbiol. 1997;35(8):2187. doi: ten.1128/JCM.35.8.2187-2187.1997. [PMC gratuitous commodity] [PubMed] [CrossRef] [Google Scholar]
• Remington J.S., Desmonts G. Toxoplasmosis. In: Remington J.S., Klein J.O., editors. Infectious Diseases of the Fetus and Newborn Infant. tertiary ed. Saunders; Philadelphia, W.B: 1990. pp. 90–195. [Google Scholar]
• Rivera Eastward.M., Lavayén Southward.N., Sánchez P., Martins C., Gómez E., Rodríguez J.P. Toxoplasma gondii seropositivity associated to peri-urban living places in pregnant women in a rural area of Buenos Aires province, Argentina. Parasite Epidemiol. Control. 2019;7:e00121. doi: 10.1016/j.parepi.2019.e00121. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
• Rorman E., Zamir C.S., Rilkis I., Ben-David H. Built toxoplasmosis–prenatal aspects of Toxoplasma gondii infection. Reprod. Toxicol. 2006;21(4):458–472. [PubMed] [Google Scholar]
• Singh South. Mother-to-child manual and diagnosis of Toxoplasma gondii infection during pregnancy. Indian J. Med. Microbiol. 2013;21(ii):69. https://world wide web.ijmm.org/text.asp?2003/21/2/69/7978 [PubMed] [Google Scholar]
• Tabor A., Philip J., Madsen M., Bang J., Obel East.B., Nørgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 depression-risk women. Lancet (London, England) 1986;ane(8493):1287–1293. [PubMed] [Google Scholar]
• Tenter A.M., Heckeroth A.R., Weiss L.M. Erratum-Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 2001;31(2):217–220. PII: S0020751900001247. [Google Scholar]
• The National Health Service UK, 2020. What are the risks of toxoplasmosis during pregnancy? https://www.nhs.united kingdom/common-health-questions/pregnancy/what-are-the-risks-of-toxoplasmosis-during-pregnancy/ (accessed fourteen September 2020).
• Torgerson P.R., Mastroiacovo P. The global brunt of congenital toxoplasmosis: a systematic review. Bull. Globe. Health. Org. 2013;91:501–508. doi: 10.2471/BLT.12.111732. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

lambersonpecausely.blogspot.com

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093533/

Share this post